Skip to content

Let me review the provided GO-CAM model based on my understanding of the model content and GO-CAM best practices:

Review of GO-CAM Model: gomodel:653b0ce600001230

Model Overview

  • Title: KSHV-ORF57 inhibition of host PKR (Human-HHV8)
  • Taxon: Human (NCBITaxon:9606)
  • Status: Production

Model Content and Structure

This GO-CAM describes the mechanism by which Kaposi's sarcoma-associated herpesvirus (KSHV) protein ORF57 inhibits the human host PKR-mediated innate immune response. The model includes 5 activities connected through causal relationships:

  1. UniProtKB:Q9BY44 (EIF2A) - translation initiation factor activity (GO:0003743)
  2. UniProtKB:P19525 (PKR/EIF2AK2) - protein kinase activity (GO:0004672)
  3. UniProtKB:Q2HR75 (KSHV ORF57) - protein sequestering activity (GO:0140311)
  4. UniProtKB:O75569 (PRKRA/PACT) - enzyme activator activity (GO:0008047)
  5. UniProtKB:P20042 (EIF2S2) - translation initiation factor activity (GO:0003743)

The causal relationships show: - ORF57 inhibits PACT through protein sequestering (RO:0012010) - PACT activates PKR (RO:0002629) - PKR inhibits EIF2A (RO:0002630) - EIF2A activates EIF2S2 (RO:0002629)

Scientific Assessment

The model accurately represents the mechanism described in the literature (PMID:29084250), where KSHV ORF57 directly binds to both PACT and PKR, preventing their interaction and subsequent PKR activation. This prevents PKR from phosphorylating eIF2α, which would otherwise inhibit translation initiation.

The model correctly captures the central role of ORF57 in disrupting the host's antiviral response by blocking stress granule formation through inhibition of the PKR pathway. This mechanism is consistent with viral strategies to maintain host cell translation machinery for viral protein synthesis.

Technical Assessment

Strengths:

  1. Correct use of molecular function terms for each protein
  2. Appropriate causal relationship predicates connecting activities
  3. Proper cellular locations indicated (cytoplasm GO:0005737)
  4. Well-evidenced with appropriate literature references
  5. Biological processes appropriately indicated:
  6. Translational initiation (GO:0006413) for translation factors
  7. Antiviral innate immune response (GO:0140374) for PKR
  8. KSHV suppression of host PKR/eIF2alpha signaling (GO:0039580) for viral ORF57

Areas for Improvement:

  1. Missing Complex Representation: The model doesn't explicitly represent the eIF2 complex, which includes EIF2S1, EIF2S2, and EIF2S3. According to the "How to annotate complexes in GO-CAM" guidelines, when specific subunits carry known activities, they should be represented individually, which is done here, but the relationship to the complex could be clarified.

  2. Phosphorylation Representation: While the causal relationships are correct, the specific molecular detail that PKR phosphorylates eIF2α isn't explicitly captured in the model. It's implied by the protein kinase activity, but using a more specific term for phosphorylation might improve the model's clarity.

  3. PMID Citation Issue: One of the references (PMID:248628414) appears to be incorrect as it contains too many digits for a standard PMID. This should be verified and corrected.

  4. Completeness: The model doesn't capture that the ultimate effect of this pathway is inhibition of stress granule formation, which is a key biological outcome described in the primary paper. This could be included to provide a more complete picture of the biological significance.

Recommendation

This GO-CAM model is scientifically accurate and technically well-constructed. It effectively captures the core mechanism by which KSHV ORF57 inhibits the host PKR-mediated antiviral response. The model follows most GO-CAM best practices and provides valuable insights into virus-host interactions.

To further enhance this model, I recommend: 1. Correcting the potentially erroneous PMID citation 2. Considering the addition of the stress granule formation inhibition as a downstream effect 3. Potentially clarifying the relationship between the individual eIF2 subunits and the complex 4. Adding a more specific term to capture the phosphorylation aspect of PKR activity on eIF2α

Overall, this model is valid and provides a useful representation of the KSHV ORF57 inhibition of host PKR pathway, which helps explain how this virus evades host antiviral defense mechanisms.